Epilepsy Clinical Trial
Official title:
Search for Genes Influencing Childhood Absence Epilepsy Study
The purpose of our study is to identify gene(s) involved in the cause of childhood absence epilepsy (CAE).
A high familial predisposition for epilepsy in patients with childhood absence epilepsy
(CAE), also called petit mal epilepsy, suggests underlying genetic causes contributing to
the disease. Several areas harboring potential absence epilepsy genes have been identified
in the genome.
This study will further narrow down those areas and identify gene(s) involved in the cause
of CAE by taking several approaches: 1. Comparing patients with CAE to healthy individuals
without epilepsy and 2. Investigating whole families with many members affected with
epilepsy).
Participation in this study requires an interview regarding medical and family history and
saliva (spit) collection from all available family members of families with many epilepsy
cases. For those families without a history of epilepsy, parents and children are asked to
provide a small amount of saliva only. Healthy volunteers without epilepsy or a family
history of seizures are asked to fill out an anonymous questionnaire and provide a small
amount of saliva as well.
Although the study is based at Mount Sinai School of Medicine in New York, all study
materials can be sent to your home at no cost to participants or their insurance. For the
collection of saliva, special containers are provided and they can be shipped back to Mount
Sinai in the pre-paid envelope provided. Study materials can be completed at your
convenience.
Results from this study may enable scientists to understand the cause of absence seizures
and, perhaps, other types of seizures as well and with this laying the foundation for better
diagnosis and treatment of epilepsy patients in the future.
;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04595513 -
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants
|
Phase 1/Phase 2 | |
Completed |
NCT02909387 -
Adapting Project UPLIFT for Blacks in Georgia
|
N/A | |
Completed |
NCT05552924 -
Self Acupressure on Fatigue and Sleep Quality in Epilepsy Patients
|
N/A | |
Terminated |
NCT01668654 -
Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS
|
Phase 3 | |
Not yet recruiting |
NCT05068323 -
Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients
|
N/A | |
Completed |
NCT03994718 -
Creative Arts II Study
|
N/A | |
Recruiting |
NCT04076449 -
Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
|
||
Completed |
NCT00782249 -
Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy
|
N/A | |
Completed |
NCT03683381 -
App-based Intervention for Treating Insomnia Among Patients With Epilepsy
|
N/A | |
Recruiting |
NCT05101161 -
Neurofeedback Using Implanted Deep Brain Stimulation Electrodes
|
N/A | |
Active, not recruiting |
NCT06034353 -
Impact of Pharmacist-led Cognitive Behavioral Intervention on Adherence and Quality of Life of Epileptic Patients
|
N/A | |
Recruiting |
NCT05769933 -
Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
|
||
Not yet recruiting |
NCT06408428 -
Glioma Intraoperative MicroElectroCorticoGraphy
|
N/A | |
Not yet recruiting |
NCT05559060 -
Comorbidities of Epilepsy(Cognitive and Psychiatric Dysfunction)
|
||
Completed |
NCT02977208 -
Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use
|
Phase 4 | |
Completed |
NCT02646631 -
Behavioral and Educational Tools to Improve Epilepsy Care
|
N/A | |
Completed |
NCT02952456 -
Phenomenological Approach of Epilepsy in Patients With Epilepsy
|
||
Recruiting |
NCT02539134 -
TAK-935 Multiple Rising Dose Study in Healthy Participants
|
Phase 1 | |
Completed |
NCT02491073 -
Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL)
|
N/A | |
Terminated |
NCT02757547 -
Transcranial Magnetic Stimulation for Epilepsy
|
N/A |